We ensure high-quality execution of global trials

Scientific Investigator Networks are a vital element in the academic as well as the clinical research setting. Among peers in the scientific community, investigators communicate and collaborate directly contributing to the advance of study imperatives. For this reason, within the clinical research setting, advantages are gained when coordinated research networks are maintained and managed.

In the course of years Julius Clinical has set up and invested in the following networks:

•             PCRN (Primary Care Research Network);
•             ReSViNET (RSV network).


ReSViNET was founded in Utrecht, The Netherlands on January 14, 2014 by nine clinicial scientists and Julius Clinical as a fully independent research network with the mission to decrease the global burden of RSV infection. The founding members, who share many values professionally, had already been connected through research, education or other network activities. 

Currently ReSViNET is stimulating and performing research to better understand the burden of RSV infection, to advocate for better care for patients with RSV infection, to provide education related to RSV infection and to provide effective partnerships with relevant stakeholders. 

Please visit the ReSViNET website for more information about this network.


The Primary Care Research Network (PCRN) focuses on performing high-quality research by utilising a group of motivated and qualified general practitioners, pharmacists, practice assistants and practice nurses with an interest in clinical scientific research.

The Julius Clinical research network works closely with the Julius Center for Health Sciences and Primary Care at the UMC Utrecht.

In the Netherlands, the Julius Clinical Primary Care Research Network (PCRN) comprises nearly 1,000 medical professionals who are involved in clinical (drug) research, co-ordinated in the primary care setting by Julius Clinical.

Please visit the PCRN website to learn more about this network.